The US government paid a company US$13.8 million five years ago to develop a cheap version of a ventilator that could be used to confront a pandemic, yet none will be added to the national stockpile any time soon. The company is supposed to deliver them by 2022 and is meanwhile busy selling ventilators abroad at higher rates, Propublica reported this week.